# Regorafenib-Tablets-Market-Report
Industry revenue for Regorafenib Tablets is estimated to rise to $2.6 billion by 2035 from $1.2 billion of 2024. The revenue growth of market players is expected to average at 7.1% annually for the period 2024 to 2035.
